Erbitux
Active substance: cetuximab
cetuximab
Centralised EU authorisationActive
Marketing holder: Merck Europe B.V.
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 5 |
|
| US 2 |
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-525d-719c-b36d-b6dfe91710a1,01a120c3-d460-749a-9809-52e651488f69,01a120c4-11e9-715b-abfe-b9f00368424d;count=3 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-b291-7bb5-a9ba-3c1a544f35e6,01a1209d-f166-7a30-abaf-8f92f1ea20ca;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/000558
- Registration status
- Active
- ATC code
- L01FE01
Sources
- product · EMA · EMEA/H/C/000558 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/000558 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/000558 · Verified 2026-10-09